Advertisement

Topics

Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals

16:20 EDT 10 Aug 2018 | Xconomy

The FDA has approved a new treatment for Fabry disease, a decision that represents the end of a winding, more than decade-long saga for the drug’s developer, Amicus Therapeutics. Its long journey also highlights how drug approval in the U.S. has changed just in the last two years, thanks to new FDA leadership and recent […]

Original Article: Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals

NEXT ARTICLE

More From BioPortfolio on "Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...